Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.665
-0.024 (-3.44%)
At close: Dec 5, 2025, 4:00 PM EST
0.680
+0.016 (2.36%)
After-hours: Dec 5, 2025, 7:44 PM EST
Immunic Employees
Immunic had 91 employees as of December 31, 2024. The number of employees increased by 14 or 18.18% compared to the previous year.
Employees
91
Change (1Y)
14
Growth (1Y)
18.18%
Revenue / Employee
n/a
Profits / Employee
-$1,132,385
Market Cap
79.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMUX News
- 10 days ago - Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December - PRNewsWire
- 23 days ago - Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 5 weeks ago - Immunic to Participate in Industry and Investor Conferences in November - PRNewsWire
- 2 months ago - Immunic to Participate in Scientific and Investor Conferences in October - PRNewsWire
- 2 months ago - Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis - PRNewsWire
- 3 months ago - Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis - PRNewsWire
- 3 months ago - Immunic to Participate in Investor and Scientific Conferences in September - PRNewsWire
- 4 months ago - Immunic (IMUX) Q2 Loss Widens 25% - The Motley Fool